Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Werewolf Therapeutics Inc
HOWLCurrent price
1.93 USD
-0.11 USD (-5.39%)
Last closed
2.15 USD
Company
werewolftx.com
ISIN
US95075A1079
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
100 514 824 USD
Yield for 12 month
-12.27 %
1Y
3Y
5Y
10Y
15Y
HOWL
Werewolf Therapeutics, Inc., a biopharmaceutical company, develops therapeutics engineered to stimulate the body's immune system for the treatment of cancer. The company, through its proprietary PREDATOR platform, designs conditionally activated molecules that stimulate adaptive and innate immunity for addressing the limitations of conventional proinflammatory immune therapies. Its lead product candidates are WTX-124, a conditionally activated Interleukin-2 INDUKINE molecule that is in Phase I/Ib clinical trial for the treatment of advanced or metastatic solid tumors; and WTX-330, a conditionally activated Interleukin-12 INDUKINE molecule, which is in Phase I clinical trial for the treatment of advanced or metastatic solid tumors and lymphoma. The company is also developing JZP898, a conditionally activated interferon alpha INDUKINE molecule for the treatment of cancer; and WTX-712, an activated Interleukin-21(IL-21) and WTX-518, an activated IL-18 (IL-18) INDUKINE molecule for the treatment of cancer. Werewolf Therapeutics, Inc. was incorporated in 2017 and is headquartered in Watertown, Massachusetts. Address: 200 Talcott Ave, Watertown, MA, United States, 02472
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
12 USDP/E ratio
–Dividend Yield
–Current Year
+19 943 000 USD
Last Year
+16 401 000 USD
Current Quarter
–
Last Quarter
+1 143 000 USD
Current Year
+18 179 000 USD
Last Year
+16 401 000 USD
Current Quarter
–
Last Quarter
+689 000 USD
Key Figures HOWL
1 year
3 years
5 years
10 years
EBITDA
-64 376 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-26.16 %
PEG Ratio
–
Return On Equity TTM
-61.56 %
Wall Street Target Price
12 USD
Revenue TTM
3 386 000 USD
Book Value
2.04 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-85.9 %
Dividend Yield
–
Gross Profit TTM
-37 360 000 USD
Earnings per share
-1.38 USD
Diluted Eps TTM
-1.38 USD
Most Recent Quarter
III 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics HOWL
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History HOWL
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation HOWL
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
0.2034
Price Sales TTM
29.6854
Enterprise Value EBITDA
0.5683
Price Book MRQ
0.9663
Financials HOWL
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators HOWL
For 52 weeks
1.66 USD
8.19 USD
50 Day MA
2.27 USD
Shares Short Prior Month
1 038 599
200 Day MA
3.96 USD
Short Ratio
5.4
Shares Short
775 986
Short Percent
3.03 %
BeatStart